Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $9,800 | 2 | 75.8% |
| Travel and Lodging | $2,080 | 8 | 16.1% |
| Food and Beverage | $879.56 | 12 | 6.8% |
| Education | $172.07 | 5 | 1.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Alexion Pharmaceuticals, Inc. | $12,603 | 21 | $0 (2024) |
| Biogen, Inc. | $165.97 | 3 | $0 (2024) |
| Sarepta Therapeutics, Inc. | $95.00 | 1 | $0 (2023) |
| ARGENX US, INC. | $35.95 | 1 | $0 (2023) |
| MITSUBISHI TANABE PHARMA AMERICA, INC. | $31.11 | 1 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $4,640 | 12 | Alexion Pharmaceuticals, Inc. ($4,491) |
| 2023 | $215.07 | 4 | Sarepta Therapeutics, Inc. ($95.00) |
| 2022 | $8,028 | 9 | Alexion Pharmaceuticals, Inc. ($8,028) |
| 2021 | $31.11 | 1 | MITSUBISHI TANABE PHARMA AMERICA, INC. ($31.11) |
| 2018 | $16.67 | 1 | Biogen, Inc. ($16.67) |
All Payment Transactions
27 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/19/2024 | Alexion Pharmaceuticals, Inc. | ULTOMIRIS (Biological) | Consulting Fee | Cash or cash equivalent | $3,430.00 | General |
| Category: Rare Disease | ||||||
| 10/19/2024 | Alexion Pharmaceuticals, Inc. | ULTOMIRIS (Biological) | Travel and Lodging | In-kind items and services | $308.98 | General |
| Category: Rare Disease | ||||||
| 10/19/2024 | Alexion Pharmaceuticals, Inc. | ULTOMIRIS (Biological) | Food and Beverage | In-kind items and services | $112.42 | General |
| Category: Rare Disease | ||||||
| 10/19/2024 | Alexion Pharmaceuticals, Inc. | ULTOMIRIS (Biological) | Travel and Lodging | Cash or cash equivalent | $104.12 | General |
| Category: Rare Disease | ||||||
| 10/19/2024 | Alexion Pharmaceuticals, Inc. | ULTOMIRIS (Biological) | Food and Beverage | In-kind items and services | $81.91 | General |
| Category: Rare Disease | ||||||
| 10/19/2024 | Alexion Pharmaceuticals, Inc. | ULTOMIRIS (Biological) | Food and Beverage | Cash or cash equivalent | $17.57 | General |
| Category: Rare Disease | ||||||
| 10/18/2024 | Alexion Pharmaceuticals, Inc. | ULTOMIRIS (Biological) | Travel and Lodging | In-kind items and services | $299.25 | General |
| Category: Rare Disease | ||||||
| 10/18/2024 | Alexion Pharmaceuticals, Inc. | ULTOMIRIS (Biological) | Food and Beverage | In-kind items and services | $84.77 | General |
| Category: Rare Disease | ||||||
| 10/17/2024 | Biogen, Inc. | SPINRAZA (Biological) | Food and Beverage | In-kind items and services | $138.19 | General |
| Category: Neurology | ||||||
| 10/17/2024 | Biogen, Inc. | SPINRAZA (Biological) | Food and Beverage | In-kind items and services | $11.11 | General |
| Category: Neurology | ||||||
| 08/07/2024 | Alexion Pharmaceuticals, Inc. | ULTOMIRIS (Biological) | Education | In-kind items and services | $50.00 | General |
| Category: Rare Disease | ||||||
| 06/19/2024 | Alexion Pharmaceuticals, Inc. | ULTOMIRIS (Biological) | Education | In-kind items and services | $2.00 | General |
| Category: Rare Disease | ||||||
| 05/16/2023 | ARGENX US, INC. | VYVGART (Drug) | Education | In-kind items and services | $35.95 | General |
| Category: Immunology | ||||||
| 03/20/2023 | Sarepta Therapeutics, Inc. | — | Food and Beverage | In-kind items and services | $95.00 | General |
| 02/16/2023 | Alexion Pharmaceuticals, Inc. | ULTOMIRIS (Biological) | Education | In-kind items and services | $50.00 | General |
| Category: Rare Disease | ||||||
| 02/16/2023 | Alexion Pharmaceuticals, Inc. | ULTOMIRIS (Biological) | Education | In-kind items and services | $34.12 | General |
| Category: Rare Disease | ||||||
| 12/20/2022 | Alexion Pharmaceuticals, Inc. | ULTOMIRIS (Biological) | Consulting Fee | Cash or cash equivalent | $6,370.00 | General |
| Category: Rare Disease | ||||||
| 12/20/2022 | Alexion Pharmaceuticals, Inc. | ULTOMIRIS (Biological) | Travel and Lodging | Cash or cash equivalent | $73.75 | General |
| Category: Rare Disease | ||||||
| 12/20/2022 | Alexion Pharmaceuticals, Inc. | ULTOMIRIS (Biological) | Travel and Lodging | Cash or cash equivalent | $52.00 | General |
| Category: Rare Disease | ||||||
| 12/20/2022 | Alexion Pharmaceuticals, Inc. | ULTOMIRIS (Biological) | Travel and Lodging | Cash or cash equivalent | $23.69 | General |
| Category: Rare Disease | ||||||
| 12/20/2022 | Alexion Pharmaceuticals, Inc. | ULTOMIRIS (Biological) | Food and Beverage | Cash or cash equivalent | $8.00 | General |
| Category: Rare Disease | ||||||
| 12/03/2022 | Alexion Pharmaceuticals, Inc. | ULTOMIRIS (Biological) | Travel and Lodging | In-kind items and services | $781.21 | General |
| Category: Rare Disease | ||||||
| 12/03/2022 | Alexion Pharmaceuticals, Inc. | ULTOMIRIS (Biological) | Travel and Lodging | In-kind items and services | $436.78 | General |
| Category: Rare Disease | ||||||
| 12/03/2022 | Alexion Pharmaceuticals, Inc. | ULTOMIRIS (Biological) | Food and Beverage | In-kind items and services | $140.85 | General |
| Category: Rare Disease | ||||||
| 12/02/2022 | Alexion Pharmaceuticals, Inc. | ULTOMIRIS (Biological) | Food and Beverage | In-kind items and services | $141.96 | General |
| Category: Rare Disease | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 7 | 149 | 237 | $35,747 | $10,083 |
| 2022 | 10 | 242 | 353 | $58,355 | $15,817 |
| 2021 | 10 | 260 | 414 | $68,565 | $17,892 |
| 2020 | 11 | 274 | 404 | $58,646 | $17,551 |
All Medicare Procedures & Services
38 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2023 | 23 | 30 | $9,300 | $3,262 | 35.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 28 | 36 | $7,704 | $2,261 | 29.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2023 | 26 | 38 | $5,624 | $1,756 | 31.2% |
| 95910 | Nerve conduction, 7-8 studies | Facility | 2023 | 12 | 13 | $3,887 | $909.98 | 23.4% |
| 95885 | Needle measurement of electrical activity in arm or leg muscles, limited study | Facility | 2023 | 32 | 59 | $3,776 | $719.35 | 19.1% |
| 95886 | Needle measurement of electrical activity in arm or leg muscles, complete study | Facility | 2023 | 12 | 17 | $2,414 | $591.79 | 24.5% |
| 95874 | Needle measurement of electrical activity in muscle with injection of chemical for paralysis of nerve muscle | Facility | 2023 | 16 | 44 | $3,042 | $583.08 | 19.2% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2022 | 21 | 26 | $8,060 | $2,700 | 33.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2022 | 34 | 47 | $6,956 | $2,057 | 29.6% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 17 | 33 | $5,445 | $1,835 | 33.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 22 | 28 | $5,992 | $1,795 | 30.0% |
| 95912 | Nerve conduction, 11-12 studies | Facility | 2022 | 14 | 14 | $6,482 | $1,713 | 26.4% |
| 95911 | Nerve conduction, 9-10 studies | Facility | 2022 | 17 | 17 | $6,647 | $1,509 | 22.7% |
| 95910 | Nerve conduction, 7-8 studies | Facility | 2022 | 19 | 19 | $5,985 | $1,414 | 23.6% |
| 95885 | Needle measurement of electrical activity in arm or leg muscles, limited study | Facility | 2022 | 51 | 93 | $5,952 | $1,206 | 20.3% |
| 95886 | Needle measurement of electrical activity in arm or leg muscles, complete study | Facility | 2022 | 25 | 30 | $4,260 | $1,066 | 25.0% |
| 95874 | Needle measurement of electrical activity in muscle with injection of chemical for paralysis of nerve muscle | Facility | 2022 | 22 | 46 | $2,576 | $521.90 | 20.3% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Facility | 2021 | 41 | 57 | $8,276 | $2,953 | 35.7% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Facility | 2021 | 25 | 30 | $8,946 | $2,757 | 30.8% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Facility | 2021 | 26 | 36 | $7,524 | $2,504 | 33.3% |
| 95910 | Nerve transmission studies, 7-8 studies | Facility | 2021 | 23 | 24 | $7,476 | $1,755 | 23.5% |
| 95912 | Nerve transmission studies, 11-12 studies | Facility | 2021 | 15 | 15 | $6,928 | $1,566 | 22.6% |
| 95885 | Needle measurement and recording of electrical activity of muscles of arm or leg limited study | Facility | 2021 | 53 | 115 | $7,206 | $1,561 | 21.7% |
| 64646 | Injection of chemical for destruction of nerve muscles on trunk, 5 or more muscles | Facility | 2021 | 12 | 25 | $8,400 | $1,500 | 17.9% |
| 95911 | Nerve transmission studies, 9-10 studies | Facility | 2021 | 15 | 15 | $5,849 | $1,467 | 25.1% |
About Dr. Shumaila Sultan, MD
Dr. Shumaila Sultan, MD is a Internal Medicine healthcare provider based in Morgantown, West Virginia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/02/2008. The National Provider Identifier (NPI) number assigned to this provider is 1942462734.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Shumaila Sultan, MD has received a total of $12,931 in payments from pharmaceutical and medical device companies, with $4,640 received in 2024. These payments were reported across 27 transactions from 5 companies. The most common payment nature is "Consulting Fee" ($9,800).
As a Medicare-enrolled provider, Sultan has provided services to 925 Medicare beneficiaries, totaling 1,408 services with total Medicare billing of $61,343. Data is available for 4 years (2020–2023), covering 38 distinct procedure/service records.
Practice Information
- Specialty Internal Medicine
- Other Specialties Neurology
- Location Morgantown, WV
- Active Since 07/02/2008
- Last Updated 04/08/2022
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1942462734
Products in Payments
- ULTOMIRIS (Biological) $12,603
- SPINRAZA (Biological) $165.97
- VYVGART (Drug) $35.95
- RADICAVA (Drug) $31.11
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Morgantown
Dr. Partho Sengupta, Md, Dm, MD, DM
Internal Medicine — Payments: $152,664
Dr. Ashkan Emadi, Md, Phd, MD, PHD
Internal Medicine — Payments: $123,347
Dr. Latoya Linton-Frazier, Md, MD
Internal Medicine — Payments: $72,467
Ward Paine, Md, MD
Internal Medicine — Payments: $69,016
Dr. John Nasr, Md, MD
Internal Medicine — Payments: $35,066
Dr. Matthew Gaskill, D.o, D.O
Internal Medicine — Payments: $21,227